Osaic Holdings’s Pharming Group PHAR Stock Holding History

Osaic Holdings’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-16	Closed	-$222	–	8190
2026 Q2	$222	Sell	16 -112	-88%	-$1.62K	﹤0.01%	7767
2026 Q1	$2.13K	Buy	+128	New	+$2.17K	﹤0.01%	7026
2025 Q1	–	Sell	-483	Closed	-$4.86K	–	7654
2024 Q4	$4.86K	Buy	+483	New	+$4.12K	﹤0.01%	6209
2024 Q3	–	Sell	-568	Closed	-$4.74K	–	7517
2024 Q2	$4.74K	Buy	+568	New	+$5.35K	﹤0.01%	6200

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Silver Grove Financial Group Orchard Park, New York $214M AUM 19.83% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Osaic Holdings's PHAR Position: Q3 2026 in Review

Osaic Holdings sold out of Pharming Group (PHAR) in Q3 2026, closing a stake of 16 shares — an estimated $222 sold.

Osaic Holdings first reported a position in PHAR in Q2 2024 and held it in 4 quarters. The position peaked at $4.86K in Q4 2024. 6 funds tracked by Wall St. Rank hold PHAR as of Q3 2026.

Osaic Holdings reported no remaining Pharming Group position as of Q3 2026 after selling out during the quarter.
Osaic Holdings sold 16 Pharming Group shares in Q3 2026, an estimated $222.
Osaic Holdings first reported a position in Pharming Group in Q2 2024 and held it in 4 quarters.
Osaic Holdings's Pharming Group position peaked at $4.86K in Q4 2024.
6 funds tracked by Wall St. Rank held Pharming Group as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.